AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Antibody for Tubulointerstitial Nephritis Antigen

Technology Benefits
Easy to produceSpecies-specific
Detailed Technology Description
Identification of species-specific epitopes for generating antibodies against tubulointerstitial nephritis antigen (TINag) #researchtool #antibody #therapeutics
*Abstract

Northwestern researchers have developed a method for production of species-specific tubulointerstitial antigen (TINag) antibodies. Tubulointerstitial kidney disorders are known to develop due to the presence of TINag, which stimulates production of auto-reactive antibodies. If TINag antibodies are produced, the disease progresses rapidly, leading to kidney failure. Therefore, study of TINag and TINag specific antibodies is a crucial step to understanding severe kidney disease and discovering therapies against it. Until the development of this innovative method by Prof. Kanwar and colleagues, TINag antibody production was a cumbersome and labor-intensive process. This TINag antibody production method could accelerate the pace of kidney disease research enabling development of therapeutics in the future. 

*Inventors
Yashpal Kanwar* Ping Xie
Country/Region
USA

For more information, please click Here
Mobile Device